Plus Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 23, 2023
AUSTIN, Texas, Feb. 14, 2023 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult to treat cancers, announced that the Company will report fourth quarter and full year 2022 financial results on Thursday, February 23, 2023, after market close. Plus Therapeutics’ management team will then host a conference call and webcast at 5:00 p.m. ET to discuss the financial results and provide a corporate update.
Related news for (PSTV)
- Breaking News: MoBot’s Latest Update as of 08/06/25 01:00 PM
- Breaking News: MoBot’s Latest Update as of 08/05/25 08:00 AM
- Breaking News: MoBot’s Latest Update as of 08/04/25 11:00 AM
- Plus Therapeutics Provides US Launch Update for its CNSide® Diagnostic
- Breaking News: MoBot’s Latest Update as of 07/31/25 08:00 AM